Solar eclipse 2024: When and where to watch the phenomenon
04:43
How the Baltimore bridge collapsed after the cargo ship collision
04:18
Will Princess Kate’s cancer revelation ease the pressure on her?
04:16
What will happen to TikTok if the U.S. bans the app?
04:46
American sailor becomes first woman to race solo around the world
04:01
Voters cite immigration as top issue while Biden, Trump visit border
04:33
Alabama health providers halt IVF after court ruling
05:02
Are massive sports stadiums worth taxpayers’ money?
04:27
Social media companies pushed to improve child safety
04:52
Electric vehicle drivers face battery struggles in record cold
04:35
Swatting incidents on the rise amid political divisions in the US
04:18
Inside the massive boom of artificial intelligence in 2023
04:15
Holiday package theft on the rise as porch pirate warning issued
04:08
Streaming bundles points to future of subscription services
04:23
What is behind Elon Musk’s recent divisive nature?
04:40
How artificial intelligence can pick out holiday gifts for you
03:56
Third-party candidates aim to disrupt Biden-Trump rematch in 2024
04:36
New drugs revolutionizing weight-loss and health care
04:34
Meta denies claim its business model maximizes kids’ screen time
05:15
Experimental Alzheimer’s drug shows promising results in patients
04:38
Copied
Copied
An experimental drug for Alzheimer's was found to reduce cognitive decline in patients significantly, offering a potential breakthrough against the devastating disease. NBC’s Maggie Vespa reports in this week’s Sunday Focus on the risks and how soon the drug might be available.Dec. 4, 2022